NSI-189 vs P21 (Adamax)

Overview

NSI-189 and P21 (Adamax) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares NSI-189 and P21 (Adamax) across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. NSI-189 is categorised under Cognitive Enhancement, while P21 (Adamax) falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. NSI-189: not FDA-approved; treated as a research compound. P21 (Adamax): not FDA-approved; treated as a research compound.

Dosing. NSI-189 is typically dosed at Research protocols vary (research). P21 (Adamax) is typically dosed at 5-20 mg (intermittent).

Can you stack them?

Some protocols combine peptides, but stacking NSI-189 and P21 (Adamax) has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between NSI-189 and P21 (Adamax)?

NSI-189 and P21 (Adamax) are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. NSI-189 is not FDA-approved; generally classified as a research compound, whereas P21 (Adamax) is not FDA-approved; generally classified as a research compound.

What is NSI-189 used for?

Neurogenesis, depression.

What is P21 (Adamax) used for?

Neurogenic peptide.

Can you take NSI-189 and P21 (Adamax) together?

Some users combine peptides within a single protocol, but stacking NSI-189 and P21 (Adamax) has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is NSI-189 or P21 (Adamax) FDA-approved?

NSI-189 is not FDA-approved; generally classified as a research compound. P21 (Adamax) is not FDA-approved; generally classified as a research compound.